Examination of the epidemiology investigation in the rheumatoid arthritis new onset patient
Not Applicable
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000025537
- Lead Sponsor
- Division of Rheumatology, Takarazuka City Hospital.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with rheumatoid arthritis received some kind of treatments with DMARD.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Possession rate of antibodies and their titer, such as rheumatoid factor, anti-SSA/Ro antibody and anti- cyclic citrullinated peptide antibody in non-treatment after the rheumatoid arthritis onset. And possession rate of risk factors (ex; gender, smoking habit, periodontitis, bronchitis and interstitial pneumonitis) in conjunction with these antibody instructions.
- Secondary Outcome Measures
Name Time Method Evaluation of the influence that antibodies and an antibody instruction risks give in an episode of care of the rheumatoid arthritis (as follows) 1) Disease activity scores (Week 0, 24, 52) 2) Functional assessment with HAQDI (week 0, 24, 52) 3) Radiographic assessment (Week 0, 24, 52) 4) Possession rates of bronchitis and interstitial penumonitis (Week 0, 52) with chest CT and measurement of vital capacity by a spirometer and flow-volume curve, carbon monoxide lung diffusing capacity.